Santalis FDA phase 2 details

https://clinicaltrials.gov/ct2/show/NCT02993328

	Column 1	Column 2
0	Estimated Enrollment:	72
1	Anticipated Study Start Date:	December 2017
2	Estimated Study Completion Date:	June 2018
3	Estimated Primary Completion Date:	May 2018 (Final data collection date for primary outcome measure)

There's some incentive.